Quick Answer
MEDIFAST INC reported Cash and Equivalents of $89.30 million for fiscal year 2025.
MEDIFAST INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $89.30M | -1.8% |
| 2024 | $90.93M | -3.7% |
| 2023 | $94.44M | +7.7% |
| 2022 | $87.69M | -15.8% |
| 2021 | $104.18M | -36.4% |
| 2020 | $163.72M | +112.7% |
| 2019 | $76.97M | -5.4% |
| 2018 | $81.36M | +8.4% |
| 2017 | $75.08M | +43.2% |
| 2016 | $52.44M | +24.7% |
| 2015 | $42.04M | +71.9% |
| 2014 | $24.46M | -32.8% |
| 2013 | $36.38M | -8.9% |
| 2012 | $39.94M | +180.0% |
| 2011 | $14.26M | -16.9% |
| 2010 | $17.16M | +61.9% |
| 2009 | $10.60M | +989.8% |
| 2008 | $973.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $99.53M | -13.7% | -2.1% |
| June 30, 2025 | $101.69M | -5.9% | +10.9% |
| March 31, 2025 | $91.72M | -5.9% | +0.9% |
| December 31, 2024 | $90.93M | -3.7% | -21.1% |
| September 30, 2024 | $115.31M | +2.3% | +6.7% |
| June 30, 2024 | $108.02M | -26.7% | +10.8% |
| March 31, 2024 | $97.47M | -21.2% | +3.2% |
| December 31, 2023 | $94.44M | +7.7% | -16.2% |
- MEDIFAST INC showed a decrease of -1.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, MEDIFAST INC’s cash and equivalents has grown by 9078.1% (from $973.0 thousand to $89.30 million).
- The most recent figure is from MEDIFAST INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: